Femasys Inc. (NASDAQ:FEMY – Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 1,740,000 shares, a growth of 55.4% from the March 15th total of 1,120,000 shares. Currently, 8.5% of the shares of the stock are short sold. Based on an average daily […]
Femasys (NASDAQ:FEMY – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Chardan Capital in a research note issued to investors on Monday, Benzinga reports. They currently have a $12.00 price target on the stock. Other analysts have also issued reports about the company. HC Wainwright lifted their price target on […]
Femasys (NASDAQ:FEMY – Get Free Report) and Steakholder Foods (OTCMKTS:MTTCF – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Femasys and Steakholder […]
Femasys (NASDAQ:FEMY – Get Free Report) and Beyond Air (NASDAQ:XAIR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability. Valuation & Earnings This table compares Femasys and […]
Femasys (NASDAQ:FEMY – Get Free Report) and Beyond Air (NASDAQ:XAIR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation. Profitability This table compares Femasys and Beyond Air’s […]